Overtreatment in surgery - does it concern also the patients with ductal breast carcinoma in situ

被引:4
作者
Nowikiewicz, Tomasz [1 ]
Zegarski, Wojciech [1 ]
Glowacka-Mrotek, Iwona [2 ]
机构
[1] Nicolaus Copernicus Univ Torun, Ludwik Rydygiers Coll Med Bydgoszcz, Chair & Dept Surg Oncol, Oncol Ctr,Prof Franciszek Lukaszczyk Mem Hosp Byd, Torun, Poland
[2] Nicolaus Copernicus Univ Torun, Ludwik Rydygiers Coll Med Bydgoszcz, Dept Rehabil, Torun, Poland
关键词
overtreatment; overdiagnosis; surgical treatment; breast cancer; ductal carcinoma in situ;
D O I
10.5604/01.3001.0011.5964
中图分类号
R61 [外科手术学];
学科分类号
摘要
Overtreatment means treatment that goes beyond current standards, and patients with any disease can be over-treated. Overtreatment is also given to patients with cancer, including those who need surgery. Overtreatment is closely related to the problem of overdiagnosis. In patients with cancer, unnecessary surgery may cause complications and generates unnecessary costs. The size of the problem of unnecessary surgery in patients with cancer can best be shown among patients with the most common cancers, which dedicated screening programs. Breast cancer patients, particularly those with pre-invasive types of the tumor, who typically have ductal carcinoma in situ (80%), are likely to undergo unnecessary surgery. We describe the most common clinical problems caused by overtreating patients with ductal carcinoma in situ.
引用
收藏
页码:47 / 50
页数:4
相关论文
共 39 条
  • [1] Allred D. Craig, 2010, Journal of the National Cancer Institute Monographs, P134, DOI 10.1093/jncimonographs/lgq035
  • [2] Abolishing Mammography Screening Programs? A View from the Swiss Medical Board
    Biller-Andorno, Nikola
    Jueni, Peter
    Kalager, Mette
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (21) : 1965 - 1967
  • [3] Bleyer A, 2005, NEW ENGL J MED, V367, P21
  • [4] The molecular pathology of breast cancer progression
    Bombonati, Alessandro
    Sgroi, Dennis C.
    [J]. JOURNAL OF PATHOLOGY, 2011, 223 (02) : 307 - 317
  • [5] Ductal Carcinoma in Situ at Core-Needle Biopsy: Meta-Analysis of Underestimation and Predictors of Invasive Breast Cancer
    Brennan, Meagan E.
    Turner, Robin M.
    Ciatto, Stefano
    Marinovich, M. Luke
    French, James R.
    Macaskill, Petra
    Houssami, Nehmat
    [J]. RADIOLOGY, 2011, 260 (01) : 119 - 128
  • [6] Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study
    Elshof, Lotte E.
    Tryfonidis, Konstantinos
    Slaets, Leen
    van Leeuwen-Stok, A. Elise
    Skinner, Victoria P.
    Dif, Nicolas
    Pijnappel, Ruud M.
    Bijker, Nina
    Rutgers, Emiel J. Th.
    Wesseling, Jelle
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 (12) : 1497 - 1510
  • [7] The natural history of ductal carcinoma in situ of the breast:: a review
    Erbas, B
    Provenzan, E
    Armes, J
    Gertig, D
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2006, 97 (02) : 135 - 144
  • [8] Breast conserving treatment for ductal carcinoma in situ in the elderly: Can radiation therapy be avoided? Our experience
    Falco, Giuseppe
    Rocco, Nicola
    Procaccini, Eugenio
    Sommella, Maria Giulia
    Bordoni, Daniele
    Cenini, Eugenio
    Castagnetti, Fabio
    Sabatino, Vincenzo
    Compagna, Rita
    Della Corte, Gianni Antonio
    Accurso, Antonello
    Amato, Bruno
    Ferrari, Guglielmo
    [J]. INTERNATIONAL JOURNAL OF SURGERY, 2014, 12 : S47 - S49
  • [9] The LORIS Trial: Addressing Overtreatment of Ductal Carcinoma In Situ
    Francis, A.
    Fallowfield, L.
    Rea, D.
    [J]. CLINICAL ONCOLOGY, 2015, 27 (01) : 6 - 8
  • [10] Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
    Goldhirsch, A.
    Wood, W. C.
    Coates, A. S.
    Gelber, R. D.
    Thuerlimann, B.
    Senn, H. -J.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 (08) : 1736 - 1747